News

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...
Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...
In an interview with Dr. Phil, the health secretary offered false information about vaccine oversight and revealed a lack of ...
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...
The FDA and other HHS agencies of interest to the pharma sphere have seen President Donald Trump’s first 100 days as he ...
This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation ...
The first 100 days of the second Trump administration have brought a number of healthcare reversals. Here are 10 of them, ...